Latest News
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
19 January 2026 - Healthcare technology company Apiject Holdings Inc announced on Friday that it has signed a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina.The new facility is planned to house two advanc...
Atossa Therapeutics' (Z)-endoxifen receives US FDA Orphan Drug Designation to treat Duchenne muscular dystrophy
19 January 2026 - Clinical-stage biopharmaceutical company Atossa Therapeutics Inc (Nasdaq:ATOS) announced on Friday that it has received Orphan Drug Designation from the US Food and Drug Administration (FDA) Office of Orphan Products Development (OO...
Profusa launches Lumee tissue oxygen system for CRO market
16 January 2026 - US-based digital health company Profusa, Inc. (NASDAQ: PFSA), which develops tissue-integrated biosensors for continuous biochemical monitoring, announced on Friday the launch of a healthcare research version of its Lumee tissue oxy...
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed
16 January 2026 - China-based medical technology company Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190) said on Friday that it has entered into a definitive agreement to acquire Germany-based Optimed Medizinische Instrumente GmbH in multip...
European Commission approves Sobi's Aspaveli for rare kidney diseases
16 January 2026 - Swedish biopharmaceutical company Sobi (STO: SOBI) said on Friday that the European Commission has approved Aspaveli (pegcetacoplan) for use in adults and adolescents aged 12 to 17 with C3 glomerulopathy (C3G) or primary immune-comp...